Dhar A - Search Results

1

Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.

Dhar A, Hu J, Reeves R, Resar LM, Colburn NH. Dhar A, et al. Oncogene. 2004 May 27;23(25):4466-76. doi: 10.1038/sj.onc.1207581. Oncogene. 2004. PMID: 15064752

2

The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Dhar A, Young MR, Colburn NH. Dhar A, et al. Mol Cell Biochem. 2002 May-Jun;234-235(1-2):185-93. Mol Cell Biochem. 2002. PMID: 12162432 Review.

3

Nitric oxide does not mediate but inhibits transformation and tumor phenotype.

Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NH. Dhar A, et al. Mol Cancer Ther. 2003 Dec;2(12):1285-93. Mol Cancer Ther. 2003. PMID: 14707269

4

Re: 'Dedicated service for Barrett's oesophagus surveillance endoscopy yields higher dysplasia detection and guideline adherence in a non-tertiary setting in the UK: a 5-year comparative cohort study' by Ratcliffe et al.

Dhar A. Dhar A. Frontline Gastroenterol. 2023 Oct 3;15(3):264. doi: 10.1136/flgastro-2023-102541. eCollection 2024 May. Frontline Gastroenterol. 2023. PMID: 38665792 Free article. No abstract available.

5

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.

Chanchlani N, Lin S, Bewshea C, Hamilton B, Thomas A, Smith R, Roberts C, Bishara M, Nice R, Lees CW, Sebastian S, Irving PM, Russell RK, McDonald TJ, Goodhand JR, Ahmad T, Kennedy NA; PANTS Consortium. Chanchlani N, et al. Lancet Gastroenterol Hepatol. 2024 Apr 16:S2468-1253(24)00044-X. doi: 10.1016/S2468-1253(24)00044-X. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 38640937 Free article.

6

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial.

Patel VC, McPhail MJ, Uddin R, Jafari H, Lawrence V, Le Boutillier C, Shearer J, Yaziji N, Cape A, Ahmed H, Ward C, Walsh P, Besly K, Zamalloa A, Kelly J; BOPPP study group; Carter B. Patel VC, et al. Trials. 2024 Apr 16;25(1):265. doi: 10.1186/s13063-024-08063-3. Trials. 2024. PMID: 38627804 Free PMC article.

7

Functional redundancy and formin-independent localization of tropomyosin isoforms in Saccharomyces cerevisiae.

Dhar A, Bagyashree VT, Biswas S, Kumari J, Sridhara A, Jeevan Subodh B, Shekhar S, Palani S. Dhar A, et al. bioRxiv [Preprint]. 2024 Apr 4:2024.04.04.587703. doi: 10.1101/2024.04.04.587703. bioRxiv. 2024. PMID: 38617342 Free PMC article. Preprint.

8

Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges.

Bhagi M, Kaur J, Dhar A, Bhat A. Bhagi M, et al. Among authors: dhar a. Curr Pharm Biotechnol. 2024 Apr 2. doi: 10.2174/0113892010287216240324050651. Online ahead of print. Curr Pharm Biotechnol. 2024. PMID: 38566388

9

A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice.

Cao S, Budina E, Raczy MM, Solanki A, Nguyen M, Beckman TN, Reda JW, Hultgren K, Ang PS, Slezak AJ, Hesser LA, Alpar AT, Refvik KC, Shores LS, Pillai I, Wallace RP, Dhar A, Watkins EA, Hubbell JA. Cao S, et al. Among authors: dhar a. Nat Biomed Eng. 2024 Apr 1. doi: 10.1038/s41551-024-01190-x. Online ahead of print. Nat Biomed Eng. 2024. PMID: 38561491

10

When the pelvic water balloon isn't the bladder. A rare case of a seminal vesicle cystic tumour causing lower urinary tract symptoms.

Zhuo KY, Razi B, Kovacic J, Shepherd A, Dhar A, Rasiah K. Zhuo KY, et al. Among authors: dhar a. ANZ J Surg. 2024 Mar 26. doi: 10.1111/ans.18999. Online ahead of print. ANZ J Surg. 2024. PMID: 38529735 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

836 results

Search Page